3D-printed device could facilitate point-of-care drug combination testing

A team of researchers has developed a 3D-printed device that could enable clinicians to test personalized drug combinations at the point of care. A team of scientists from the Institute of Physical Chemistry of the Polish Academy of Sciences (IPC, PAS; Warsaw, Poland) has developed a novel device, reportedly capable of testing antibiotic combinations in fewer than 12 hours and for thousands of samples at a time. Described in Micromachines, the team claims that the device - designed to replace strip tests used at the point-of-care - is cost-efficient, fast and reliable, suggesting that the device may provide patients with a stronger chance of fighting...